GenPath logo in conjunction with women's health

Sexual and Reproductive Health

Testing through GenPath Women’s Health improves the quality of care using targeted detection in the diagnosis of STIs and other vaginal infections.

GenPath utilizes Multiplex Polymerase Chain Reaction (PCR) based on proprietary technology, which is able to identify multiple pathogens from a single vial. Our PCR DNA amplification technique provides high specificity and sensitivity compared to other methods.

One Collection, Targeted Detection

GenPath offers simplicity of collection with one universal liquid preparation vial and no need for multiple collection devices.

High Sensitivity, High Specificity

GenPath’s molecular testing options definitively identify pathogens to allow for more targeted treatment. It is especially useful for detecting mixed infections and its performance is not affected by collection variables like menses.

Convenience Of Testing

The results of GenPath tests come from one laboratory in a concise, easy-to-read report.

Clinically Relevant Profiles

Testing profiles should be ordered based on patient history in conjunction with relevant clinical signs and symptoms.

Profiles

High Risk STI Profiles

For patients with new or multiple sex partners, patients in a high-risk demographic (under the age of 25), and/or those who are having unprotected sex. Test for chamydia and gonorrhea with the opton of adding trichomonas and/or mycoplasma genitalium.

Cervicitis Profile

For patients with visible purulent or mucopurulent exudates from the cervical canal, endocervical bleeding, and/or ulcerative lesions on the ectocervix. Test for chlamydia, gonorrhea, trichomonas, mycoplasma genitalium, and herpes simplex virus type 1 and type 2.

PID/Infertility/Pregnancy Loss Profile

For patients with symptoms of pelvic inflammatory diseases (PID) including lower abdominal pain, painful intercourse, painful urination and/or irregular menstrual bleeding. Patients may also have difficulty getting pregnant or experience multiple pregnancy losses. Tests for infections known to cause PID, including chlamydia, gonorrhea, trichomonas, mycoplasma, bacterial vaginosis organisms, aerobic vaginitis organisms, and ureaplasma.

Bacterial Vaginosis Profile

For symptomatic female patients with dysuria, pruritis, dyspareunia, vaginal discharge, or fishy vaginal odor. Discharge, when present, is usually milky white, but can be yellow or grey. Detects and quantifies lactobacillus species (non-pathogenic), gardnerella vaginalis, and atopobium vaginae. Detects megasphaera type 1 and bacterial vaginosis associated bacterium 2 (BVAB2). BV determination requires testing of all five organisms.

Aerobic Vaginitis (AV) Profile

For symptomatic female patients with dysuria, pruritis, dyspareunia, vaginal discharge, or foul vaginal odor. Detects and quantifies lactobacillus species (non-pathogenic) and detects Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Group A Streptococcus and Group B Streptococcus. AV determination requires testing of all five organisms.

Vulvovaginal Candidiasis Profile

For symptomatic females with dysuria, pruritis, dyspareunia and curd-like vaginal discharge. Tests for candida genus and candida albicans. If candida genus is positive and candida albicans is negative, the profile will reflex to five candida species (C. dubliniensis, C. parapsilosis, C. tropicalis, C. glabrata and C. krusei).

Lesion Profiles

For patients presenting with papules, pustules, vesicles and/or ulcers on mucocutaneous tissue in the genital, anal, or oral areas. Profiles test for a combination of herpes simplex virus type 1 and type 2, varicella zoster virus and Treponema pallidum. Testing for LGV and CMV are also available as individual tests.

Disease/Infection/ConditionResponsible Organisms
ChlamydiaChlamydia trachomatis (CT)
GonorrheaNeisseria gonorrhea (GC) (NG)
TrichomoniasisTrichomonas vaginalis
Mycoplasma genitalium (M. gen)Mycoplasma genitalium
Bacterial Vaginosis (BV)Anaerobic bacteria species including: Gardnerella vaginalis, Atopobium vaginae, Megasphaera Type 1, Bacterial Vaginosis-Associated Bacterium 2 (BVAB2) (not part of panel but can be added – Mobiluncus species)
Aerobic Vaginitis (AV)Aerobic bacteria species including: Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Group A Streptococcus, Group B Streptococcus
Vulvovaginal CandidasisCandida species (yeast): Candida genus, candida albicans C. glabrata, C. dubliniensis, C. parapsilosis, C. tropicalis, C. krusei
Pelvic Inflammatory Disease (PID)CT, GC, Mycoplasma genitalium, Ureaplasma, Anaerobic Bacteria, Aerobic Bacteria, Trichomonas vaginalis
SyphilisTreponema pallidum
HerpesHerpes Simplex Virus (HSV) type 1 and type 2
©2019 GenPath, a division of BioReference Laboratories Inc., an OPKO Health Company